Subspecialties: Page 645

Radiation safety from the medical physicist's perspective
By David Jordan, Neomi Mullens
The call to action regarding patient radiation dose safety has flooded the healthcare industry with a wide array of new options, recommendations, requirements, and regulations that are pushing organizations to revamp radiation safety initiatives across the board.
November 4, 2014
2013 05 31 14 24 53 75 Ascendian Logo 200
PET/MRI compares well with PET/CT for pancreatic cancer
By Wayne Forrest
Thursday, December 4 | 11:40 a.m.-11:50 a.m. | SSQ06-08 | Room E350Italian researchers are adding to the evidence that PET/MRI can benefit cancer patients for use in tumor-node-metastasis staging.
November 4, 2014
PET/MRI adds to lung cancer diagnoses
By Wayne Forrest
Wednesday, December 3 | 11:40 a.m.-11:50 a.m. | SSK18-08 | Room S505ABBritish researchers have concluded that PET/MRI appears to be a "robust technique" for preoperative staging of lung cancer patients, offering "significantly lower radiation dose."
November 4, 2014
Researchers make PET/MRI scans more tolerable for young patients
By Wayne Forrest
Wednesday, December 3 | 11:30 a.m.-11:40 a.m. | SSK18-07 | Room S505ABResearchers at Lucile Packard Children's Hospital and Stanford University School of Medicine have found a way to streamline FDG-PET/MRI scans to make them more tolerable for children with lymphoma and sarcoma.
November 4, 2014
Infants with congenital hyperinsulinism can benefit from PET/MRI
By Wayne Forrest
Wednesday, December 3 | 11:20 a.m.-11:30 a.m. | SSK19-06 | Room S102ABSimultaneous PET/MRI with fluorine-18 dihydroxyphenylalanine matches PET/CT in the preoperative differentiation of congenital hyperinsulinism among pediatric patients -- while delivering less radiation.
November 4, 2014
Time-of-flight PET/MRI could help with a variety of clinical applications
By Wayne Forrest
Wednesday, December 3 | 11:10 a.m.-11:20 a.m. | SSK18-05 | Room S505ABTime-of-flight PET/MRI provided comparable image quality and diagnostic ability to PET/CT in several clinical applications in a study from Stanford University.
November 4, 2014
PET/MRI could benefit NSCLC patients with less radiation, adequate imaging
By Wayne Forrest
Wednesday, December 3 | 10:40 a.m.-10:50 a.m. | SSK18-02 | Room S505ABWith radiation exposure to patients a constant concern, whole-body staging with PET/MRI could greatly benefit patients with non-small cell lung cancer (NSCLC), according to a study from University Hospital Zurich.
November 4, 2014
Study helps differentiate Alzheimer's from mild cognitive impairment
By Wayne Forrest
Monday, December 1 | 3:50 p.m.-4:00 p.m. | SSE19-06 | Room S505ABBy combining visual and quantitative analysis of FDG-PET brain images, clinicians can improve diagnostic accuracy for detecting hypometabolic patterns that could indicate mild cognitive impairment in elderly patients with hypertension and memory complaints.
November 4, 2014
PiB-PET proves useful for Alzheimer's and poststroke dementia
By Wayne Forrest
Monday, December 1 | 3:30 p.m.-3:40 p.m. | SSE19-04 | Room S505ABIn this study, researchers are touting the prowess of PET imaging with carbon-11-labeled Pittsburgh Compound B for evaluating and differentiating Alzheimer's disease and poststroke dementia.
November 4, 2014
Study determines SUVmax cutoff for accurate solitary lung nodule prognosis
By Wayne Forrest
Monday, December 1 | 10:40 a.m.-10:50 a.m. | SSC03-02 | Room S404ABItalian researchers have determined the optimum cutoff of maximum standardized uptake value (SUVmax) for an accurate prognosis of patients with solitary lung nodules.
November 4, 2014
PET/MRI adds critical information for rectal cancer patients
By Wayne Forrest
Sunday, November 30 | 12:05 p.m.-12:15 p.m. | SSA18-09 | Room S505ABFused PET/MR images can provide a more accurate assessment of local disease extension in rectal cancer patients than FDG-PET/CT and pelvic MRI, according to researchers from Stony Brook University Hospital.
November 4, 2014
FDG-PET/CT offers insight into thyroid cancer patient survival
By Wayne Forrest
Sunday, November 30 | 11:25 a.m.-11:35 a.m. | SSA18-05 | Room S505ABFDG-PET/CT scans conducted more than six months after primary thyroid cancer treatment can enhance a patient's clinical evaluation and provide a prognostic marker of overall survival, according to this study from Johns Hopkins University.
November 4, 2014
Previous Page
Page 645 of 1546
Next Page